by Gabriel Di Blasi
Click here to download do artigo.
Recently, the Brazilian Patent and Trademark Office (BPTO) published Normative Instruction No. 74/2017. The measure, which is related
Recently, ANVISA published Resolution No. 168/2017, which sets protocols for the analysis of pharmaceutical patent applications. This Resolution
The Brazilian Patent Office (BPO) has been struggling with the patent backlog in Brazil for years. In a